Dementia Global Clinical Trials Review 2021, Featuring Eisai, Johnson & Johnson, Novartis, Eli Lilly and AstraZeneca – ResearchAndMarkets.com

Dementia Global Clinical Trials Review 2021, Featuring Eisai, Johnson & Johnson, Novartis, Eli Lilly and AstraZeneca – ResearchAndMarkets.com




Dementia Global Clinical Trials Review 2021, Featuring Eisai, Johnson & Johnson, Novartis, Eli Lilly and AstraZeneca – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Dementia – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering.

The clinical trial report provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia .

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

  • The report provides a snapshot of the global clinical trials landscape
  • The report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The report provides enrollment trends for the past five years
  • The report provides latest news for the past three months

Companies Mentioned

  • Eisai Co Ltd
  • Johnson & Johnson
  • Novartis AG
  • Eli Lilly and Co
  • C. H. Boehringer Sohn AG & Co KG
  • Otsuka Holdings Co Ltd
  • Teva Pharmaceutical Industries Ltd
  • The Lundbeck Foundation
  • AstraZeneca Plc
  • Viatris Inc

     

Key Topics Covered:

  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Dementia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Dementia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Dementia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/jh4jgt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900